Do Not Wait to Consider Life Expectancy Until After a Prostate Cancer Diagnosis
Kidney Transplantation Among Presumed Undocumented Immigrants After Changes in US State Policies
Consumer Wearables-Advancing Atrial Fibrillation Care or Too Much Information?
The Importance of Care for People Coming Home-Mass Incarceration and Human Frailty
Is the Multitarget Stool DNA Test Just a Better "FIT" for Colorectal Cancer Screening?
Clarifying Causes of Increasing Cannabis-Related ED Visits in Older Adults-Reply
Antidiabetic Medication and Asthma Attacks
Elevated body mass index (BMI) and type 2 diabetes are prevalent in asthma and are associated with an increase in the risk of asthma attacks. In experimental studies, the diabetes medications metformin and glucagon-like peptide-1 receptor agonists (GLP-1RA) have mitigated airway inflammation, hyperresponsiveness, and remodeling. However, epidemiological evidence is limited.
Over-the-Counter Medication Abortion as a Strategy to Expand Access to Care
Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening
Establishing National Standards for Carceral Health Care-The Federal Prison Oversight Act
Midline vs Peripherally Inserted Central Catheter for Outpatient Parenteral Antimicrobial Therapy
Little is known about the safety of midline catheters vs peripherally inserted central catheters (PICCs) for outpatient parenteral antimicrobial therapy (OPAT).
Clarifying Causes of Increasing Cannabis-Related ED Visits in Older Adults
Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia: A Systematic Review and Meta-Analysis
Hyponatremia treatment guidelines recommend limiting the correction of severe hyponatremia during the first 24 hours to prevent osmotic demyelination syndrome (ODS). Recent evidence suggests that slower rates of correction are associated with increased mortality.
Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era
Men with limited life expectancy (LE) have historically been overtreated for prostate cancer despite clear guideline recommendations. With increasing use of active surveillance, it is unclear if overtreatment of men with limited LE has persisted and how overtreatment varies by tumor risk and treatment type.
